$VSTM LGSOC data looks great, but a big miss in NSCLC 

The data aligns with only needed to pay $3 million for the drug, had the results been as extraordinary as expected, they would have needed to pay more IMO

#stocks #money #trading

https://t.co/v5U5k4ugNG